KNSA
Kiniksa Pharmaceuticals International, plc 9/1/2025, 2:23:57 PM
NasdaqGS
USD
EQUITY
After Hours
$33.49
+0.00 (+0.00%)
At Close
$33.49
-0.01 (-0.03%)
Volume
316,935
-59.3% vs 3M Avg
Market Cap
2.48B
NasdaqGS
Period
No AI Analysis Available
Generate a comprehensive AI analysis for KNSA to get insights on valuation, growth prospects, and investment recommendations.
Valuation
-
Profitability
1.0%
0.5%
0.6%
53.1%
0.8%
0.9%
Growth
56.2%
80.5%
-
-
119.4%
Financial Health
-
Forward Looking
Strong Buy
$40.83
-
$131.13
Mid-Cap
Risk & Technical
0.13
$34.55 / $17.82
60.98
6.2%
Shareholder Returns
-
-
-
-5.6%
2.7%